Mengis Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.8M Sell
64,483
-15,630
-20% -$1.89M 1.66% 15
2025
Q1
$8.93M Hold
80,113
1.86% 11
2024
Q4
$7.8M Buy
80,113
+600
+0.8% +$58.4K 1.59% 14
2024
Q3
$9.15M Sell
79,513
-2,092
-3% -$241K 1.8% 13
2024
Q2
$8.69M Sell
81,605
-2,188
-3% -$233K 1.76% 13
2024
Q1
$8.11M Buy
83,793
+1,850
+2% +$179K 1.25% 18
2023
Q4
$8.27M Buy
81,943
+300
+0.4% +$30.3K 1.55% 15
2023
Q3
$8.32M Sell
81,643
-50
-0.1% -$5.09K 1.73% 15
2023
Q2
$8.24M Sell
81,693
-175
-0.2% -$17.7K 1.64% 15
2023
Q1
$7.53M Sell
81,868
-390
-0.5% -$35.9K 1.59% 15
2022
Q4
$7.46M Sell
82,258
-470
-0.6% -$42.6K 1.63% 16
2022
Q3
$6.29M Sell
82,728
-3,133
-4% -$238K 1.49% 16
2022
Q2
$7.26M Sell
85,861
-135
-0.2% -$11.4K 1.59% 15
2022
Q1
$7.55M Buy
85,996
+967
+1% +$84.9K 1.45% 16
2021
Q4
$7.44M Buy
85,029
+2,350
+3% +$206K 1.4% 16
2021
Q3
$6.76M Buy
82,679
+250
+0.3% +$20.4K 1.42% 18
2021
Q2
$7.52M Buy
82,429
+1,687
+2% +$154K 1.56% 16
2021
Q1
$6.9M Buy
80,742
+7,373
+10% +$630K 1.53% 17
2020
Q4
$6.93M Buy
73,369
+44
+0.1% +$4.16K 1.68% 13
2020
Q3
$6.38M Buy
73,325
+1,233
+2% +$107K 1.75% 14
2020
Q2
$6.3M Buy
72,092
+22
+0% +$1.92K 1.87% 11
2020
Q1
$5.94M Buy
72,070
+3,440
+5% +$284K 2.03% 10
2019
Q4
$6.5M Sell
68,630
-333
-0.5% -$31.5K 1.79% 11
2019
Q3
$5.99M Sell
68,963
-50
-0.1% -$4.34K 1.79% 10
2019
Q2
$6.3M Buy
69,013
+39,729
+136% +$3.63M 1.93% 8
2019
Q1
$2.52M Sell
29,284
-78
-0.3% -$6.72K 1.41% 24
2018
Q4
$2.26M Sell
29,362
-112
-0.4% -$8.61K 1.43% 23
2018
Q3
$2.28M Sell
29,474
-306
-1% -$23.6K 1.25% 24
2018
Q2
$2.02M Buy
29,780
+55
+0.2% +$3.72K 1.19% 24
2018
Q1
$2.15M Hold
29,725
1.29% 25
2017
Q4
$2.24M Buy
29,725
+837
+3% +$63K 1.35% 24
2017
Q3
$2.22M Buy
28,888
+1,228
+4% +$94.5K 1.49% 24
2017
Q2
$2.07M Buy
27,660
+3,365
+14% +$252K 1.46% 24
2017
Q1
$1.62M Buy
+24,295
New +$1.62M 1.18% 27